<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Korean Med Sci</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Korean Med. Sci</journal-id>
      <journal-id journal-id-type="publisher-id">JKMS</journal-id>
      <journal-title-group>
        <journal-title>Journal of Korean Medical Science</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1011-8934</issn>
      <issn pub-type="epub">1598-6357</issn>
      <publisher>
        <publisher-name>The Korean Academy of Medical Sciences</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24133354</article-id>
      <article-id pub-id-type="pmc">3792604</article-id>
      <article-id pub-id-type="doi">10.3346/jkms.2013.28.10.1489</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
          <subj-group>
            <subject>Endocrinology, Nutrition &amp; Metabolism</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Genetic and Clinical Characteristics of Korean Patients with Isolated Hypoparathyroidism: From the Korean Hypopara Registry Study</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>So Young</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="author-notes" rid="FN1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Eom</surname>
            <given-names>Young Sil</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
          <xref ref-type="author-notes" rid="FN1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Choi</surname>
            <given-names>Byoungho</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yi</surname>
            <given-names>Hyon-Seung</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>Seung-Hee</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Kiyoung</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jin</surname>
            <given-names>Hyun-Seok</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chung</surname>
            <given-names>Yoon-Sok</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jung</surname>
            <given-names>Tae Sik</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Lee</surname>
            <given-names>Sihoon</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Internal Medicine, Cheil General Hospital, Kwandong University College of Medicine, Seoul, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Internal Medicine and Laboratory of Molecular Endocrinology, Gachon University School of Medicine, Incheon, Korea.</aff>
      <aff id="A3"><label>3</label>Department of Medical Genetics, Ajou University School of Medicine, Suwon, Korea.</aff>
      <aff id="A4"><label>4</label>Department of Endocrinology and Metaboilism, Ajou University School of Medicine, Suwon, Korea.</aff>
      <aff id="A5"><label>5</label>Department of Internal Medicine, Gyeongsang Institute of Health Science, Gyeongsang National University School of Medicine, Jinju, Korea.</aff>
      <author-notes>
        <fn id="FN1" fn-type="equal">
          <p><sup>*</sup>So Young Park and Young Sil Eom contributed equally to this work.</p>
        </fn>
        <corresp>Address for Correspondence: Sihoon Lee, MD. Department of Internal Medicine and Laboratory of Molecular Endocrinology, Gachon University School of Medicine, 21 Namdong-daero 774beon-gil, Namdong-gu, Incheon 405-760, Korea. Tel: +82.32-460-8207, Fax: +82.32-460-3009, <email>shleemd@gachon.ac.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>10</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>25</day>
        <month>9</month>
        <year>2013</year>
      </pub-date>
      <volume>28</volume>
      <issue>10</issue>
      <fpage>1489</fpage>
      <lpage>1495</lpage>
      <history>
        <date date-type="received">
          <day>04</day>
          <month>6</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>01</day>
          <month>8</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2013 The Korean Academy of Medical Sciences.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Isolated hypoparathyroidism (IH) shows heterogeneous phenotypes and can be caused by defects in a variety of genes. The goal of our study was to determine the clinical features and to analyze gene mutations in a large cohort of Korean patients with sporadic or familial IH. We recruited 23 patients. They showed a broad range of onset age and various values of biochemical data. Whole exome sequencing was performed on two affected cases and one unaffected individual in a family. All coding exons and exon-intron borders of <italic>GCMB</italic>, <italic>CASR</italic>, and <italic>prepro-PTH</italic> were sequenced using PCR-amplified DNA. In one family who underwent the whole exome sequencing analysis, approximately 300 single nucleotide changes emerged as candidates for genetic alteration. Among them, we identified a functional mutation in exon 2 of <italic>GCMB</italic> (C106R) in two affected cases. Besides, heterozygous gain-of-function mutations in the <italic>CASR</italic> gene were found in other subjects; D410E and P221L. We also found one single nucleotide polymorphism (SNP) in the <italic>prepro-PTH</italic> gene, five SNPs in the <italic>CASR</italic> gene, and four SNPs in the <italic>GCMB</italic> gene. The current study represents a variety of biochemical phenotypes in IH patients with the molecular genetic diagnosis of IH.</p>
      </abstract>
      <kwd-group>
        <kwd>CASR</kwd>
        <kwd>GCMB</kwd>
        <kwd>Hypocalcemia</kwd>
        <kwd>Hypoparathyroidism</kwd>
        <kwd>Prepro-PTH</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Hypoparathyroidism, a disorder of parathyroid hormone (PTH) absence or deficiency, causes hypocalcemia and hyperphosphatemia (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). Postoperative hypoparathyroidism is the most common etiology of hypoparathyroidism (<xref rid="B3" ref-type="bibr">3</xref>). Other causes are autoimmune destruction of the parathyroid glands and congenital disorder, such as DiGeorge syndrome (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>).</p>
      <p>Isolated hypoparathyroidism (IH) is defined as hypoparathyroidism related to an isolated endocrinopathy. IH is a rare disease and its molecular and clinical properties are known to be heterogeneous. In order to overcome the rarity and complexity of IH, several studies have been conducted as a multi-center survey (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>). Clinically, patients with IH have shown a broad spectrum of features, from severe symptomatic hypocalcemia in early infancy to asymptomatic, incidental finding in adulthood. Biochemically, IH presents with a wide range of serum calcium and PTH levels. Molecular genetic studies have reported on identification of several genetic mutations, including the <italic>prepro-PTH</italic>, calcium-sensing receptor (<italic>CASR</italic>), and glial cell missing B (<italic>GCMB</italic>) in patients with hypoparathyroidism, however, in most idiopathic cases of hypoparathyroidism, the genetic defect remains unknown (<xref rid="B8" ref-type="bibr">8</xref>-<xref rid="B11" ref-type="bibr">11</xref>).</p>
      <p>Exome sequencing is useful for analysis of selective coding mutations of the human genome for discovery of novel genes for either rare or common disorders. Recently, use of exome sequencing has led to successful discovery of multiple causative gene mutations of genetic diseases (<xref rid="B12" ref-type="bibr">12</xref>).</p>
      <p>In this study, we recruited 23 patients with hypocalcemia and low serum levels of PTH from eight adult endocrine units in Korea (the Korean Hypopara Registry Study). We present mutational analysis, which can be attributed to the genetic basis of hypoparathyroidism by adopting a whole exome sequencing approach in Korean patients with IH and demonstrate the phenotypic features.</p>
    </sec>
    <sec sec-type="materials|methods">
      <title>MATERIALS AND METHODS</title>
      <sec>
        <title>Subjects</title>
        <p>Since 2010, 23 subjects have been included in the Korean Hypopara Registry Study. The inclusion criteria were the presence of hypocalcemia, an inappropriately normal or low level of serum intact PTH, and normal renal function. Patients with post-surgical hypoparathyroidism or other endocrine diseases causing PTH defects were excluded. Blood samples were collected from subjects.</p>
        <p>Serum levels of calcium, phosphate, creatinine, and intact PTH were evaluated in all subjects. Ionized calcium, albumin, magnesium, vitamin D metabolites (25-hydroxyvitamin D [25 (OH)D], or 1,25-dihydroxyvitamin D [1,25(OH)<sub>2</sub>D]) and renal calcium excretion per day were determined in selected subjects.</p>
      </sec>
      <sec>
        <title>Whole exome sequencing</title>
        <p>Whole exome sequencing was performed using genomic DNA of the affected cases (patients No. 1 and No. 2 in <xref ref-type="table" rid="T1">Table 1</xref>) and the younger brother of patient No.1 as a negative control at the Theragen BiO Institute (Suwon, Korea). The qualified genomic DNA sample was randomly fragmented using Covaris and the size of the library fragments was mainly distributed between 150 to 200 bp. Adapters were then ligated to both ends of the resulting fragments. The adapter-ligated templates were purified using Agencourt AMPure SPRI beads and fragments with an insert size of approximately 250 bp were excised. Extracted DNA was amplified using ligation-mediated PCR (LM-PCR), purified, and hybridized to the SureSelect Biotinylated RNA Library (BAITS) for enrichment. Hybridized fragments were bound to strepavidin beads, whereas non-hybridized fragments were washed out after 24 hr. Captured LM-PCR products were subjected to an Agilent 2100 Bioanalyzer for estimation of the magnitude of enrichment. Each captured library was then loaded onto a Hiseq2000 platform, and high-throughput sequencing was performed for each captured library in order to ensure that each sample met the desired average sequencing depth. Raw image files were processed by HCS1.4.8 for base-calling with default parameters and the sequences of each individual were generated as 90 bp pair-end reads.</p>
      </sec>
      <sec>
        <title>Raw data filtering</title>
        <p>Prior to performance of data analysis, removal of dirty raw reads, which only harbor the sequence of the adapter, is essential. The raw data filtering steps were; 1) removal of reads with the adapter, 2) removal of low quality reads (the percentage of low quality bases of quality value&#x2264;5 is more than the read). We confirmed a dirty reads rate of 6.6% and a clean reads rate of 93.4%. The mean read depth for the exome sequence was 49x, with 98% of the exome covering clean reads.</p>
      </sec>
      <sec>
        <title>Bioinformatics analysis</title>
        <p>To improve raw alignment BAMs for single nucleotide variation (SNV) and InDel calling, we performed depth 5-200&#xD7; and HARD_TO_VALIDATE: MQ0&#x2265;4 &amp; (MQ0/[1.0<sup>*</sup>DP])&gt;0.1) with StandBiasFilter: SB&#x2265;-1.0 of condition using GATK. In the next step, patient sample variants were filtered against variants of the control sample and dbSNP data with variants for the InHouse database.</p>
      </sec>
      <sec>
        <title>Genetic analysis</title>
        <p>Genomic DNA was extracted from peripheral blood from all patients using a standard method. All coding exons and intron-exon junctions for the <italic>prepro-PTH</italic> (NM_000315.2, NP_000306.1), <italic>CASR</italic> (NM_000388.3, NP_000379.2), and <italic>GCMB</italic> (NM_004752.3, NP_004743.1) genes were amplified and sequenced. PCR was performed using 5 mM MgCl<sub>2</sub>, 200 &#xB5;M deoxyribonucleotides, 0.5 &#xB5;M of each primer, 1 unit of <italic>Taq</italic> polymerase, and 100 ng of genomic DNA as a template. The sequences of primers are available upon request. The PCR products were electrophoresed through polyacrylamide gels and read in both directions using an ABI 377 DNA sequencer (Applied Biosystems, Foster City, CA, USA).</p>
      </sec>
      <sec>
        <title>Ethics statement</title>
        <p>The study was approved by the institutional review board (IRB) of Gachon University Gil Medical Center, Korea (IRB No. GIRBA2151). Informed consent was obtained from all subjects before participation.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>RESULTS</title>
      <sec>
        <title>Clinical and biochemical features</title>
        <p>We describe baseline clinical and biochemical characteristics of 23 patients (12 males and 11 females) with IH; six subjects of familial type from three families and 17 sporadic cases (<xref ref-type="table" rid="T1">Table 1</xref>). Three families with IH showed an association with the <italic>GCMB</italic> mutation (C106R) and <italic>CASR</italic> mutation (D410E and P221L), respectively. The mean age at onset was 34.6&#xB1;21.2 yr (range of onset age, 0-67 yr), and three patients had hypocalcemia in early infancy. All patients had a mean calcium level of 6.1&#xB1;1.1 mg/dL (range 4.4-7.8 mg/dL; <xref ref-type="table" rid="T1">Table 1</xref>), with a mean phosphate concentration of 5.7&#xB1;1.4 mg/dL (range 3.2-8.5 mg/dL). For the 22 patients with available data, serum levels of intact PTH were below 8.0 pg/mL in 17 cases or inappropriately normal despite the presence of hypocalcemia (n=5). Vitamin D metabolites were available for 18 patients; mean 1,25(OH)<sub>2</sub>D level, 38.5&#xB1; 23.6 pg/mL (n=12) and mean 25(OH)D level, 21.6&#xB1;11.7 ng/mL (n=16), respectively.</p>
      </sec>
      <sec>
        <title>Whole exome sequencing</title>
        <p>We focused on a family in which a proband and her affected offspring were diagnosed with autosomal dominant hypoparathyroidism (patients No. 1 and No. 2 in <xref ref-type="table" rid="T1">Table 1</xref>), and performed whole exome sequencing on these two individuals and the proband's sibling, an unaffected individual. A summary of the filtration strategy and numbers of resulting variants is shown in <xref ref-type="fig" rid="F1">Fig. 1</xref>. We obtained 216,260 variants from patient No. 1 and 409,709 variants from patient No. 2, respectively (<xref ref-type="fig" rid="F1">Fig. 1</xref>). We selected the intersection of two sets (patient No. 1 and patient No. 2) and obtained 33,883 variants. Then, we filtered out 27,811 overlapping variants identified from the unaffected individual. The remaining 6,072 variants were then filtered against dbSNP data and the InHouse database, removing all previously reported variants. After filtering, a total of 294 variants (181 single nucleotide variations and 73 insertions with 40 deletions) were identified as being shared by the two affected subjects. All genetic data on the variants are available upon request. Of the 294 variants, we selected 22 candidate genes that reside in coding regions and have lower BLOSUM62 (BLOcks of Amino Acid SUbstitution Matrix) score (http://icb.med.cornell.edu/education/courses/introtobio/BLOSUM62), higher PolyPhen2 score, and lower SIFT score, which might be related to significant amino acid changes and therefore may disease-causing (<xref ref-type="table" rid="T2">Table 2</xref>). <xref ref-type="table" rid="T2">Tables 2</xref> and <xref ref-type="table" rid="T3">3</xref> show final candidate variants related to hypoparathyroidism in patients with familial IH. Among the 22 variants, we noted the C106R mutation in the <italic>GCMB</italic> gene and confirmed this mutation by direct target gene-sequencing. Functional studies confirmed that <italic>GCMB</italic> C106R mutant as a loss-of-function mutation could explain hypoparathyroidism in the previous study (<xref rid="B11" ref-type="bibr">11</xref>).</p>
      </sec>
      <sec>
        <title>Mutational analysis</title>
        <p>Direct sequencing analysis detected a total of 12 different genetic defects. They are five variants in the <italic>GCMB</italic> gene, including one functional mutation, six variants in the <italic>CASR</italic> gene, including two activating mutations and one variant in the <italic>prepro-PTH</italic> gene. In addition to the C106R mutation of the <italic>GCMB</italic> gene, four single nucleotide polymorphisms (SNPs) were found in the <italic>GCMB</italic> gene (c.-44T&gt;C [rs16870746], c.91-242A&gt;G [rs9379881], c.343+163G&gt;A [rs9393726], and c.583-72A&gt;T [rs2076257]) in our cohort (<xref ref-type="table" rid="T4">Table 4</xref>).</p>
        <p>We also found an activating mutation of the <italic>CASR</italic> gene (c.1230T &gt;A [D410E]) (patient No. 8 in <xref ref-type="table" rid="T4">Table 4</xref>), which we reported as a novel mutation in the previous study (<xref rid="B13" ref-type="bibr">13</xref>). Another mutation of the <italic>CASR</italic> gene (c.662C&gt;T [P221L]) was detected in one family (patient No. 15, patient No. 16, and patient No. 17 in <xref ref-type="table" rid="T4">Table 4</xref>); this mutation was previously known as a functional mutation (<xref rid="B14" ref-type="bibr">14</xref>). In addition, five SNPs in the <italic>CASR</italic> gene (c.2205G&gt;A, c.2824G&gt;A [rs76327999], c.2956G&gt;T [rs1801725], c.2968A&gt;G [rs1042636], and c.3031G&gt;C [rs1801726]) were identified from six subjects. Finally, one SNP in the genes encoding <italic>prepro-PTH</italic> (c.247C&gt;A [rs6256]) was identified in two patients (<xref ref-type="table" rid="T4">Table 4</xref>).</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Here we report on a nation-wide study representing genetic and clinical assessment in 23 patients with IH. IH is a heterogeneous group of disorders with various genetic mutations; mainly <italic>PTH</italic> and <italic>CASR</italic> genes affecting PTH secretion, and <italic>GCMB</italic> genes related to parathyroid embryogenesis (<xref rid="B15" ref-type="bibr">15</xref>). In our series, IH results from three different mutations which have been described in the literature (P221L in the <italic>CASR</italic> gene) (<xref rid="B14" ref-type="bibr">14</xref>), including two by our group (C106R in the <italic>GCMB</italic> gene and D410E in the <italic>CASR</italic> gene) (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B13" ref-type="bibr">13</xref>). We showed that IH patients possessed several SNPs in the <italic>PTH</italic>, <italic>CASR</italic>, or <italic>GCMB</italic> genes regardless of accompanying functional mutations.</p>
      <p>In our search for candidate genes in patients with IH, we made combined use of genomic tools, such as exome sequencing and direct target gene-sequencing. Whole exome sequencing is a new and powerful tool for elucidation of the genetic basis of unsolved Mendelian diseases and could be considered for use as a diagnostic method in congenital diseases (<xref rid="B12" ref-type="bibr">12</xref>). However, identification of disease-related variants among a large background of non-pathogenic polymorphism is always challenging (<xref rid="B16" ref-type="bibr">16</xref>). In this study, whole exome sequencing revealed that heterozygous c.316T&gt;C (C106R) in the <italic>GCMB</italic> gene was one of the causal variants responsible for IH. However, other candidate genes identified by whole exome sequencing suggested that each gene might provide insights regarding contributions to hypoparathyroidism. For example, the frequency of HLA-DRB1<sup>*</sup>01 and DRB1<sup>*</sup>09 alleles was reported to be higher among patients with idiopathic hypoparathyroidism and the <italic>HLA-DRB1</italic> gene showed an association with CASR autoantibody positivity (<xref rid="B17" ref-type="bibr">17</xref>). Therefore, testing for <italic>HLA-DRB1</italic> mutation might be helpful in the effort to obtain additional information on an autoimmune component of disease among patients with IH in our cohort.</p>
      <p>Using a direct sequencing approach, we found four SNPs in the <italic>GCMB</italic> gene from nine cases. Although mutations in <italic>GCMB</italic> genes are known to have a role in pathogenesis of hypoparathyroidism, considerable allelic variability for the <italic>GCMB</italic> gene has been detected in healthy individuals (<xref rid="B15" ref-type="bibr">15</xref>); and noncritical single-nucleotide change or non-functional heterozygous mutation in the <italic>GCMB</italic> gene is easily identified in IH patients (<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B18" ref-type="bibr">18</xref>).</p>
      <p>Direct sequencing analysis of the <italic>CASR</italic> gene in our IH cohort revealed two activating mutations, the D410E mutation and the P221L mutation. In addition, we found four SNPs in the <italic>CASR</italic> gene. Among these <italic>CASR</italic> variants, two SNPs (R990G and A986S) were reported as relatively common exonic variants (<xref rid="B19" ref-type="bibr">19</xref>). In our study, the R990G allele was detected in four patients (17.4%) and A986S was detected in only one patient. Some studies have reported an association of the A986S polymorphism with serum calcium levels in healthy adults, however, other studies did not report this association (<xref rid="B20" ref-type="bibr">20</xref>-<xref rid="B23" ref-type="bibr">23</xref>). Genome-wide association scans in European and Indian Asian cohorts indicated an association of A986S with higher serum calcium levels (<xref rid="B24" ref-type="bibr">24</xref>). One hypocalcemic patient in our cohort carried A986S as a non-significant polymorphism with allelic alterations in the <italic>GCMB</italic> and <italic>prepro-PTH</italic> genes.</p>
      <p>We gathered clinical data including biochemical values and levels of vitamin D metabolites. The hypoparathyroidism patients in this study showed similar sex ratio and a broad spectrum of onset age. Most patients in this study showed relatively normal or decreased urine calcium levels. Urinary excretion of calcium is decreased in idiopathic hypoparathyroidism and elevated in patients with gain-of-function mutation of <italic>CASR</italic> (<xref rid="B25" ref-type="bibr">25</xref>). One patient with <italic>CASR</italic> D410E mutation was hypercalciuric with urinary calcium over 300 mg and other two patients carrying <italic>CASR</italic> P221L mutation showed normal urine calcium levels. Serum calcium level or vitamin D status was not associated with urinary calcium excretion.</p>
      <p>Measurement of 25(OH)D levels is essential to rule out vitamin D deficiency as a cause of hypocalcemia. In classic vitamin D deficiency, PTH hypersecretion compensates for the tendency for the blood calcium to fall (<xref rid="B1" ref-type="bibr">1</xref>). Vitamin D insufficiency, serum 25(OH)D level &lt;20 ng/mL, is reported to be relatively common in Korea (<xref rid="B26" ref-type="bibr">26</xref>). Vitamin D insufficiency was found in nine patients (56% of measured) in our subjects with low PTH levels. 1,25(OH)<sub>2</sub>D is regulated by several factors including PTH, calcium and 25(OH)D levels. Serum 1,25(OH)<sub>2</sub>D is usually reduced in hypoparathyroidism because PTH stimulates the renal 1&#x3B1;-hydroxylase (<xref rid="B27" ref-type="bibr">27</xref>). However, synthesis of 1,25(OH)<sub>2</sub>D can be determined by 25(OH)D concentration in the absence of PTH (<xref rid="B27" ref-type="bibr">27</xref>). The level of 1,25(OH)<sub>2</sub>D in our study varied, probably depending on PTH levels or substrate concentration.</p>
      <p>Until now, several studies have attempted to identify the genetic background, prevalence, clinical characteristics and the disease course of IH by conducting a multi-center survey or via a nation-wide registry database (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B28" ref-type="bibr">28</xref>-<xref rid="B30" ref-type="bibr">30</xref>). A German survey recruiting autosomal dominant hypocalcemia patients focused on identification of the <italic>CASR</italic> gene mutations and clinical phenotypes (<xref rid="B7" ref-type="bibr">7</xref>). The Italian Register of Primary Hypoparathyroidism analyzed biochemical data in relation to the Gs&#x3B1; encoding gene, <italic>GNAS1</italic> polymorphism (<xref rid="B6" ref-type="bibr">6</xref>). The epidemiologic study reported the prevalence of IH was 7.2 per million population in Japan (<xref rid="B29" ref-type="bibr">29</xref>). Our study showed the variation of phenotypic expression of IH, which was similar to previous studies. However, we could not identify the prevalence of IH or Korean-specific genetic mutations due to relatively small numbers of cases.</p>
      <p>Our study has several limitations. In general, sampling strategies for exome sequencing involve a family-based approach which means sampling from multiple, affected individuals within a pedigree or parent-child trios and an extreme phenotypic approach which means that individuals at both ends of a phenotype distribution are selected for sequencing (<xref rid="B16" ref-type="bibr">16</xref>). We performed exome sequencing with relatively small sample numbers. Therefore, further validation of SNP detected from our study should be performed in 23 cases with sufficient additional controls. We only collected baseline clinical data of cohort subjects. Follow-up consequences of IH and details for treatment are needed in order to provide information on the long-term course of disease. Although our study did not report a new cause for PTH-deficient hypoparathyroidsm, genetic assessment showed that patients with IH carried many nonfunctional variants in the <italic>GCMB</italic>, <italic>CASR</italic> or <italic>PTH</italic> genes.</p>
      <p>The presence of CASR autoantibodies or anti-parathyroid gland antibodies is known to be involved in the pathogenesis of IH (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B31" ref-type="bibr">31</xref>). However, the causal unique markers of autoimmune hypoparathyroidism are not yet established; some anti-parathyroid antibodies have the low specificity for parathyroid tissue or anti-CASR antibody positivity varied because of differences in technique (<xref rid="B10" ref-type="bibr">10</xref>). Therefore, we focused on the validation of genetic basis in this IH cohort. Further study to investigate the presence of autoantibodies related to hypoparathyroidism might be helpful to identify causes of IH in which the genetic defect remains unrevealed.</p>
      <p>The current study, a multi-center collaborative survey conducted for the first time in Korea, demonstrates a variety of phenotypes in patients and detects the genetic mutations responsible. We show that some patients with IH carry significant nucleotide changes in the <italic>GCMB</italic>, <italic>CASR</italic>, or <italic>prepro-PTH</italic> genes. However, in an appreciable number of cases of IH, an advanced diagnostic approach such as whole exome sequencing for identification of unsolved genetic mutations may be needed.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>ACKNOWLEDGEMENTS</title>
      <p>We thank all the participants for this study.</p>
    </ack>
    <fn-group>
      <fn fn-type="supported-by">
        <p>This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning, Korea (NRF-2013R1A1A1A05005629)</p>
      </fn>
    </fn-group>
    <fn-group>
      <fn fn-type="conflict">
        <p>The authors have no conflicts of interest to disclose.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shoback</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Clinical practice. hypoparathyroidism</article-title>
          <source>N Engl J Med</source>
          <year>2008</year>
          <volume>359</volume>
          <fpage>391</fpage>
          <lpage>403</lpage>
          <pub-id pub-id-type="pmid">18650515</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yi</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Molecular understanding and assessment of hypoparathyroidism</article-title>
          <source>Endocrinol Metab</source>
          <year>2011</year>
          <volume>26</volume>
          <fpage>25</fpage>
          <lpage>32</lpage>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marx</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>Hyperparathyroid and hypoparathyroid disorders</article-title>
          <source>N Engl J Med</source>
          <year>2000</year>
          <volume>343</volume>
          <fpage>1863</fpage>
          <lpage>1875</lpage>
          <pub-id pub-id-type="pmid">11117980</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kobrynski</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Sullivan</surname>
              <given-names>KE</given-names>
            </name>
          </person-group>
          <article-title>Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes</article-title>
          <source>Lancet</source>
          <year>2007</year>
          <volume>370</volume>
          <fpage>1443</fpage>
          <lpage>1452</lpage>
          <pub-id pub-id-type="pmid">17950858</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Husebye</surname>
              <given-names>ES</given-names>
            </name>
          </person-group>
          <article-title>Functional autoantibodies cause hypoparathyroidism</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2009</year>
          <volume>94</volume>
          <fpage>4655</fpage>
          <lpage>4657</lpage>
          <pub-id pub-id-type="pmid">19959750</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Masi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Del Monte</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Gozzini</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>De Feo</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Gionata Gheri</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Neri</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Falchetti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Amedei</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Imbriaco</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mavilia</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A novel polymorphism at the GNAS1 gene associated with low circulating calcium levels</article-title>
          <source>Clin Cases Miner Bone Metab</source>
          <year>2007</year>
          <volume>4</volume>
          <fpage>139</fpage>
          <lpage>145</lpage>
          <pub-id pub-id-type="pmid">22461214</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Raue</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Pichl</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>D&#xF6;rr</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Schnabel</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Heidemann</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hammersen</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Jaursch-Hancke</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Santen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sch&#xF6;fl</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wabitsch</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Activating mutations in the calcium-sensing receptor: genetic and clinical spectrum in 25 patients with autosomal dominant hypocalcaemia - a German survey</article-title>
          <source>Clin Endocrinol (Oxf)</source>
          <year>2011</year>
          <volume>75</volume>
          <fpage>760</fpage>
          <lpage>765</lpage>
          <pub-id pub-id-type="pmid">21645025</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arnold</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Horst</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Gardella</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Baba</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Kronenberg</surname>
              <given-names>HM</given-names>
            </name>
          </person-group>
          <article-title>Mutation of the signal peptide-encoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism</article-title>
          <source>J Clin Invest</source>
          <year>1990</year>
          <volume>86</volume>
          <fpage>1084</fpage>
          <lpage>1087</lpage>
          <pub-id pub-id-type="pmid">2212001</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thakker</surname>
              <given-names>RV</given-names>
            </name>
          </person-group>
          <article-title>Genetic developments in hypoparathyroidism</article-title>
          <source>Lancet</source>
          <year>2001</year>
          <volume>357</volume>
          <fpage>974</fpage>
          <lpage>976</lpage>
          <pub-id pub-id-type="pmid">11293637</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bilezikian</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Potts</surname>
              <given-names>JT</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Brandi</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Clarke</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Shoback</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>J&#xFC;ppner</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>D'Amour</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Fox</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rejnmark</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research</article-title>
          <source>J Bone Miner Res</source>
          <year>2011</year>
          <volume>26</volume>
          <fpage>2317</fpage>
          <lpage>2337</lpage>
          <pub-id pub-id-type="pmid">21812031</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yi</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Eom</surname>
              <given-names>YS</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>IB</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>J&#xFC;ppner</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mannstadt</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Identification and characterization of C106R, a novel mutation in the DNA-binding domain of GCMB, in a family with autosomal-dominant hypoparathyroidism</article-title>
          <source>Clin Endocrinol (Oxf)</source>
          <year>2012</year>
          <volume>76</volume>
          <fpage>625</fpage>
          <lpage>633</lpage>
          <pub-id pub-id-type="pmid">22066718</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ku</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>DN</given-names>
            </name>
            <name>
              <surname>Polychronakos</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Naidoo</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Soong</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Exome sequencing: dual role as a discovery and diagnostic tool</article-title>
          <source>Ann Neurol</source>
          <year>2012</year>
          <volume>71</volume>
          <fpage>5</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="pmid">22275248</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Mun</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Eom</surname>
              <given-names>YS</given-names>
            </name>
            <name>
              <surname>Baek</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Identification and characterization of D410E, a novel mutation in the loop 3 domain of CASR, in autosomal dominant hypocalcemia and a therapeutic approach using a novel calcilytic, AXT914</article-title>
          <source>Clin Endocrinol (Oxf)</source>
          <year>2013</year>
          <volume>78</volume>
          <fpage>687</fpage>
          <lpage>693</lpage>
          <pub-id pub-id-type="pmid">23009664</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>MY</given-names>
            </name>
            <name>
              <surname>Tan</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Ki</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Jang</surname>
              <given-names>HW</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>HW</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Min</surname>
              <given-names>YK</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>MK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Autosomal dominant hypocalcemia caused by an activating mutation of the calcium-sensing receptor gene: the first case report in Korea</article-title>
          <source>J Korean Med Sci</source>
          <year>2010</year>
          <volume>25</volume>
          <fpage>317</fpage>
          <lpage>320</lpage>
          <pub-id pub-id-type="pmid">20119591</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maret</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kornfield</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Analysis of the GCM2 gene in isolated hypoparathyroidism: a molecular and biochemical study</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2008</year>
          <volume>93</volume>
          <fpage>1426</fpage>
          <lpage>1432</lpage>
          <pub-id pub-id-type="pmid">18182452</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bamshad</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Bigham</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Tabor</surname>
              <given-names>HK</given-names>
            </name>
            <name>
              <surname>Emond</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Nickerson</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Shendure</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Exome sequencing as a tool for Mendelian disease gene discovery</article-title>
          <source>Nat Rev Genet</source>
          <year>2011</year>
          <volume>12</volume>
          <fpage>745</fpage>
          <lpage>755</lpage>
          <pub-id pub-id-type="pmid">21946919</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goswami</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Kochupillai</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Rani</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kifor</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Chattopadhyay</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of calcium sensing receptor autoantibodies in patients with sporadic idiopathic hypoparathyroidism</article-title>
          <source>Eur J Endocrinol</source>
          <year>2004</year>
          <volume>150</volume>
          <fpage>9</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="pmid">14713274</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tomar</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Bora</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kaur</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Chauhan</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>YD</given-names>
            </name>
            <name>
              <surname>Goswami</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Presence and significance of a R110W mutation in the DNA-binding domain of GCM2 gene in patients with isolated hypoparathyroidism and their family members</article-title>
          <source>Eur J Endocrinol</source>
          <year>2010</year>
          <volume>162</volume>
          <fpage>407</fpage>
          <lpage>421</lpage>
          <pub-id pub-id-type="pmid">19940031</pub-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yun</surname>
              <given-names>FH</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>BY</given-names>
            </name>
            <name>
              <surname>Chase</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shuen</surname>
              <given-names>AY</given-names>
            </name>
            <name>
              <surname>Canaff</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Thongthai</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Siminovitch</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hendy</surname>
              <given-names>GN</given-names>
            </name>
            <name>
              <surname>Cole</surname>
              <given-names>DE</given-names>
            </name>
          </person-group>
          <article-title>Genetic variation at the calcium-sensing receptor (CASR) locus: implications for clinical molecular diagnostics</article-title>
          <source>Clin Biochem</source>
          <year>2007</year>
          <volume>40</volume>
          <fpage>551</fpage>
          <lpage>561</lpage>
          <pub-id pub-id-type="pmid">17320849</pub-id>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cole</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Peltekova</surname>
              <given-names>VD</given-names>
            </name>
            <name>
              <surname>Rubin</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Hawker</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Vieth</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Liew</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Hwang</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Evrovski</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hendy</surname>
              <given-names>GN</given-names>
            </name>
          </person-group>
          <article-title>A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations</article-title>
          <source>Lancet</source>
          <year>1999</year>
          <volume>353</volume>
          <fpage>112</fpage>
          <lpage>115</lpage>
          <pub-id pub-id-type="pmid">10023897</pub-id>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cole</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Vieth</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Trang</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>BY</given-names>
            </name>
            <name>
              <surname>Hendy</surname>
              <given-names>GN</given-names>
            </name>
            <name>
              <surname>Rubin</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>Association between total serum calcium and the A986S polymorphism of the calcium-sensing receptor gene</article-title>
          <source>Mol Genet Metab</source>
          <year>2001</year>
          <volume>72</volume>
          <fpage>168</fpage>
          <lpage>174</lpage>
          <pub-id pub-id-type="pmid">11161843</pub-id>
        </element-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bollerslev</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Dick</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Devine</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dhaliwal</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Prince</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
          <article-title>Calcium-sensing receptor gene polymorphism A986S does not predict serum calcium level, bone mineral density, calcaneal ultrasound indices, or fracture rate in a large cohort of elderly women</article-title>
          <source>Calcif Tissue Int</source>
          <year>2004</year>
          <volume>74</volume>
          <fpage>12</fpage>
          <lpage>17</lpage>
          <pub-id pub-id-type="pmid">14508624</pub-id>
        </element-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scillitani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Guarnieri</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>De Geronimo</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Muscarella</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Battista</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>D'Agruma</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bertoldo</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Florio</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Minisola</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hendy</surname>
              <given-names>GN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2004</year>
          <volume>89</volume>
          <fpage>5634</fpage>
          <lpage>5638</lpage>
          <pub-id pub-id-type="pmid">15531522</pub-id>
        </element-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kapur</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Beckmann</surname>
              <given-names>ND</given-names>
            </name>
            <name>
              <surname>Sehmi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kutalik</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Styrkarsdottir</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Marek</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gudbjartsson</surname>
              <given-names>DF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genome-wide meta-analysis for serum calcium identifies significantly associated SNPs near the calcium-sensing receptor (CASR) gene</article-title>
          <source>PLoS Genet</source>
          <year>2010</year>
          <volume>6</volume>
          <fpage>e1001035</fpage>
          <pub-id pub-id-type="pmid">20661308</pub-id>
        </element-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Egbuna</surname>
              <given-names>OI</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations</article-title>
          <source>Best Pract Res Clin Rheumatol</source>
          <year>2008</year>
          <volume>22</volume>
          <fpage>129</fpage>
          <lpage>148</lpage>
          <pub-id pub-id-type="pmid">18328986</pub-id>
        </element-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Choi</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Oh</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Rhee</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>SK</given-names>
            </name>
          </person-group>
          <article-title>Vitamin D insufficiency in Korea--a greater threat to younger generation: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2011</year>
          <volume>96</volume>
          <fpage>643</fpage>
          <lpage>651</lpage>
          <pub-id pub-id-type="pmid">21190984</pub-id>
        </element-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Breslau</surname>
              <given-names>NA</given-names>
            </name>
          </person-group>
          <article-title>Normal and abnormal regulation of 1,25-(OH)2D synthesis</article-title>
          <source>Am J Med Sci</source>
          <year>1988</year>
          <volume>296</volume>
          <fpage>417</fpage>
          <lpage>425</lpage>
          <pub-id pub-id-type="pmid">3063116</pub-id>
        </element-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakajima</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yamazaki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Takano</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Miyoshi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Novel gain of function mutations of the calcium-sensing receptor in two patients with PTH-deficient hypocalcemia</article-title>
          <source>Intern Med</source>
          <year>2009</year>
          <volume>48</volume>
          <fpage>1951</fpage>
          <lpage>1956</lpage>
          <pub-id pub-id-type="pmid">19915295</pub-id>
        </element-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakamura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tamakoshi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kawamura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Seino</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kasuga</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yanagawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ohno</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of idiopathic hypoparathyroidism and pseudohypoparathyroidism in Japan</article-title>
          <source>J Epidemiol</source>
          <year>2000</year>
          <volume>10</volume>
          <fpage>29</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="pmid">10695258</pub-id>
        </element-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mitchell</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Regan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cooley</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Lauter</surname>
              <given-names>KB</given-names>
            </name>
            <name>
              <surname>Vrla</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Becker</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Burnett-Bowie</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Mannstadt</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Long-term follow-up of patients with hypoparathyroidism</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2012</year>
          <volume>97</volume>
          <fpage>4507</fpage>
          <lpage>4514</lpage>
          <pub-id pub-id-type="pmid">23043192</pub-id>
        </element-citation>
      </ref>
      <ref id="B31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Rais</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Connor</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Schatz</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Muir</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Maclaren</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism</article-title>
          <source>J Clin Invest</source>
          <year>1996</year>
          <volume>97</volume>
          <fpage>910</fpage>
          <lpage>914</lpage>
          <pub-id pub-id-type="pmid">8613543</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>Filters used in analysis of the exome data and numbers of candidate variants.</p>
      </caption>
      <graphic xlink:href="jkms-28-1489-g001"/>
    </fig>
    <table-wrap id="T1" orientation="portrait" position="float">
      <label>Table 1</label>
      <caption>
        <p>Clinical and laboratory features of 23 patients with isolated hypoparathyroidism (IH) in the Korean Hypopara Registry Study</p>
      </caption>
      <graphic xlink:href="jkms-28-1489-i001"/>
      <table-wrap-foot>
        <fn>
          <p>Familial type 1, patient No.1 and patient No.2; Familial type 2, patient No.8; Familial type 3, patient No.15, patient No.16, and patient No.17. <sup>*</sup>Serum creatinine reference range is given for adults. Alb, albumin; Ca, calcium; iCa, ionized calcium; P, phosphate; Mg, magnesium; Cr, creatinine; iPTH, intact parathyroid hormone; 25(OH)D, 25-hydroxyvitamin D; 1,25(OH)<sub>2</sub>D, 1,25-dihydroxyvitamin D.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="T2" orientation="portrait" position="float">
      <label>Table 2</label>
      <caption>
        <p>Summary of single nucleotide variation (SNV) found from exome sequencing in patient No. 1 and No. 2</p>
      </caption>
      <graphic xlink:href="jkms-28-1489-i002"/>
      <table-wrap-foot>
        <fn>
          <p>The PolyPhen2 score ranges from 0 to 1. A high score indicates a variant that is more likely to be damaging (benign, possibly damaging, or probably damaging). SIFT score ranges from 0 to 1. The amino acid substitution is predicted to be damaging if is the score is &#x2264;0.05, and tolerated if the score is &gt;0.05. Primates, Placental, Vertebrate, conservative ratio among primates, placental mammals, and vertebrate species, respectively. Ch'me, chromosome; SNV, single nucleotide variation; hom/het, homozygous/heterozygous; B, Blosum62; P, PolyPhen2 score; S, SIFT score.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="T3" orientation="portrait" position="float">
      <label>Table 3</label>
      <caption>
        <p>Summary of indels found from exome sequencing in patient No. 1 and No. 2</p>
      </caption>
      <graphic xlink:href="jkms-28-1489-i003"/>
      <table-wrap-foot>
        <fn>
          <p>Primates, Placental, Vertebrate, conservative ratio among primates, placental mammals, and vertebrate species, respectively. Ch'me, chromosome; INS, insertion; DEL, deletion; hom/het, homozygous/heterozygous.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="T4" orientation="portrait" position="float">
      <label>Table 4</label>
      <caption>
        <p>Results of genetic analysis of 23 patients with IH</p>
      </caption>
      <graphic xlink:href="jkms-28-1489-i004"/>
      <table-wrap-foot>
        <fn>
          <p>Bold, mutations; roman, SNP.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
